Accelerating Drug Discovery with Human-Relevant 3D Engineered Muscle Tissue Analysis SEATTLE–(BUSINESS WIRE)–#3DEngineeredMuscleTissues—Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, today announced the commercial launch of the Mantarray™ platform for human-relevant 3D heart and skeletal engineered muscle tissue (EMT) contractility analysis. Curi’s Mantarray platform enables the discovery of new therapeutics by … [Read more…]

REDWOOD CITY, Calif.–(BUSINESS WIRE)–#COVID19—Meissa Vaccines (“Meissa”), a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, today announced that Martin Moore, Ph.D., cofounder and Chief Scientific Officer of Meissa, spoke on a panel entitled, “Innovation in Vaccine Delivery,” at the Summit on the Future of COVID-19 Vaccines hosted by The White House Office for … [Read more…]

NEW YORK–(BUSINESS WIRE)–#cancermoonshot—Medidata, a Dassault Systèmes company, is supporting the White House Cancer Moonshot initiative by working with the National Cancer Institute (NCI) to enroll patients in the Cancer Moonshot Biobank. The Biobank is a project designed to better understand how cancer develops and grows, and why some cancers stop responding to treatment. People with … [Read more…]

Scientists chosen in four categories, including new Representation In SciencE (RISE) Scholar award focused on furthering diversity, equity, inclusion and belonging in the scientific community SAN FRANCISCO–(BUSINESS WIRE)–#Biotech—The Parker Institute for Cancer Immunotherapy (PICI) is helping to forge a future without cancer, by investing in today’s top talent to train and empower the research leaders … [Read more…]

New ticker symbol (Nasdaq: QNCX) to initiate trading on August 1, 2022 SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–$CRTX–Cortexyme, Inc. (Nasdaq: CRTX) today announced that the company’s planned corporate name change to Quince Therapeutics is expected take effect on Monday, August 1, 2022. In conjunction with the corporate name change, the company plans to issue a news … [Read more…]

– Publication in Nature Communications Reports that People with Loss of Function Mutations in the INHBE Gene Have Reduced Abdominal Fat, a Favorable Metabolic Profile, and are at Lower Risk of Cardiovascular Disease and Type 2 Diabetes – – Alnylam to Pursue INHBE as a Therapeutic Target for Cardiometabolic Disease – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, … [Read more…]

Increased Provider Access to Real-Time Patient Information Means Greater Efficiency, Enhanced Safety and Lower Costs ARLINGTON, Va.–(BUSINESS WIRE)–#HealthIT–More prescribers and specialty pharmacists nationwide are adopting Surescripts Specialty Medications solutions to transform the manual process used to prescribe specialty medications, saving time and money for patients and providers. In May 2022, the number of prescribers enabled … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its second quarter 2022 financial results on Wednesday, August 10, 2022. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to … [Read more…]

IFM is the leading voice for functional medicine and advancing the transformation of health care for patients and practitioners worldwide. FEDERAL WAY, Wash.–(BUSINESS WIRE)–The Institute for Functional Medicine (IFM) is proud to announce their recent Accreditation with Commendation, awarded by the Accreditation Council for Continuing Medical Education (ACCME). IFM has been continuously accredited by the … [Read more…]

VANCOUVER, British Columbia & SAN FRANCISCO–(BUSINESS WIRE)–$ABCL—AbCellera (Nasdaq: ABCL) and Versant Ventures today announced a multi-year collaboration to discover therapeutic antibodies for multiple targets selected by Versant’s portfolio of biologics-focused biotechs. Versant and AbCellera already have enabled three of the firm’s stealth-stage companies under previous partnerships. Under the terms of the deal, Versant portfolio companies … [Read more…]